Trial Details

Recruiting
Basic Information
Clinical ID c2126
Identifier DRKS00033130
Trial Title Predicting the response to therapy of inflammatory bowel disease with infrared spectroscopy - PROPHECY
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions K51 K50;Ulcerative colitis;Crohn disease [regional enteritis]
Interventions Group 1: Prospective real-world patient cohort initiating a novel line of therapy for ulcerative colitis: Analysis of routine large intestinal biopsies with infrared spectroscopy for artificial intelligence-based prediction of response to therapy and comparison with the actual therapy outcome Group 2: Prospective real-world patient cohort initiating a novel line of therapy for colonic Crohn's disease: Analysis of routine large intestinal biopsies with infrared spectroscopy for artificial intelligence-based prediction of response to therapy and comparison with the actual therapy outcome Group 3: Prospective real-world patient cohort initiating a novel line of therapy for ileal or ileocolonic Crohn's disease: Analysis of routine ileal biopsies with infrared spectroscopy for artificial intelligence-based prediction of response to therapy and comparison with the actual therapy outcome
Participant Information
Sponsor Universitsklinikum Erlangen
City -
Country/Region Belgium;Germany;United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -